CNS Research inc. is a multi-site PPPN, (Private Practice Physician's Network). Our goal is to provide the best possible patient care by offering sophisticated and diverse pharmacological research opportunities with medications not available to the general public. Working with pharmaceutical companies, we provide cutting edge evaluations, treatment and education of central nervous systems disorders.

Our Investigators have been involved in clinical research for 20 years. We focus on research phases II, III, & IV. Therapeutic specialties are Alzheimer's Disease, Stroke, Epilepsy, Migraine Headaches, Multiple Sclerosis, and Vascular Dementia. We have worked with Miles/Bayer, Parke-Davis, Hoechst Roussel, Somerset, Merck, Interneuron, Syntex, Ortho-McNeil, Quintiles, ICON, Paragon, Premier and Parexel.

Sponsor	Drug Name	Phase	Therapeutic Area	Protocol	Enrollment Commitment	Evaluable Patients
Peptimmune	Cytokine	II	MS	MS-001	20	24
Teva	Copaxone	II	MS	Copolymer	10	6
Eli Lilly & Co	Olanzepine	II	AD	FID-US-HGIC-008”	10	8
JANSSEN	Galantamine	III	AD	GAL-USA 10 to 18	63	55
RW Johnson PRI	Topamax	III	Epilepsy	Topmat-EPMN-106	10	06
RW Johnson PRI	Topamax	III	Migrane	MIG-002	08	15
RW Johnson PRI	Topamax	III	DNP	NP-001	10	07
Praecis	Latranal	III	LBP	2145-00-03	12	11
Elan	Zonegran	III	Epilepsy	AN46046-304	06	09
SANKYO	Fidaristat	II	DNP	SNK-860-201	06	03
GSK	Sumatriptan	IIII	Migrane	SUM40299	08	09
AstraZeneca	Zomig	IIII	Migrane	311CUS/0022	10	12
ZICAM	MTX-M3	IIII	Migrane	MTX-M3	10	10
Novartis	Exelon	IIII	AD	CENA713BUS13	08	11
GSK	Lamictal	IIII	Epilepsy	LAM40124	06	03

We have a network of independent, private practice neurology, psychiatry and pain centers located in Rhode Island, Massachusetts and Connecticut . Through this network, CNS Research has established in-depth knowledge of the independent sites, patient access, capabilities, staffing, experience, etc. Through an established communication infrastructure based on a virtual private network, we have electronic databases that carry detailed information as to the sites’ current profile, including current electronic CVs for each physician and each coordinator. We have a track record with each site across all CNS, psychiatric and pain disease areas. We have historical knowledge as to patient recruitment techniques that are appropriate and successful in the local community in which the site is located. All this information results in CNS Research’s ability to start studies quicker and complete studies as scheduled or ahead of our competition.

Our Private Practice Physician's network is comprised of seven leading neurologists:

• Dr. Norman M. Gordon
  Medical Director and Vise President of CNS Research, Inc.
  Dr. Norman Gordon received his medical degree from the University of the Witwatersrand in Johannesburg, South Africa. He completed an Internal Medicine Residency at the Miriam Hospital in Providence, Rhode Island. Dr. Gordon completed a Neurology Residency at the RIH Department of Neurology, serving as Chief Resident from 1987-1988. Dr. Gordon is certified by the American Board of Psychiatry and Neurology and the American Board of Internal Medicine. He is a member of the American Academy of Neurology, the Rhode Island Medical Society, and the American Association for the Study of Headache.
  RESUME LICENSE

• Dr. Dennis Aumentado
  Dr. Dennis Aumentado received his undergraduate degree in Biology in 1979 by the University of Cincinnati. He received his medical degree in 1984 from the University of the East in Manila, Philippines. He served his internship and residency in internal medicine at Write State University in Dayton, Ohio and his residence in Neurology at the University of Pittsburgh, where he also received a Fellowship in Epilepsy.
  RESUME LICENSE

• Dr. Peter Bellafiore
  Dr. Peter J. Bellafiore offers diagnosis and treatment of general neurological conditions and disorders. Dr. Bellafiore is a physician who is highly trained to treat disorders of the nervous system, which include diseases of the brain, spinal cord, nerves, and muscles. Some of the more common conditions that a neurologist diagnoses and treats are as follows: Strokes Epilepsy (seizures) Headaches, Dementias (Alzheimer's disease), Multiple sclerosis, Parkinson's disease, Various forms of pain Dr. Bellafiore has expertise in the latest neurological technology and innovations. He emphasizes patient education and encourages patients to share in decision making.
  RESUME LICENSE

• Dr. Vladislav Zayas
  Dr. Vladislav Zayas received his Medical Doctorate from Brown University in 1989. He pursued a Medical Internship at the Miriam Hospital in Providence, Rhode Island. Dr. Zayas completed his Neurological Residency at the RIH Department of Neurology, also in Providence.
  Area of Expertise: Alzheimer's Disease, Migraine Headaches, Multiple Sclerosis.
  RESUME LICENSE

• Dr. Fred Griffith, MD
  Dr. Fred Griffith received his Medical Doctorate from the University of Rochester School of Medicine and Dentistry in 1978. He completed his residency at the New England Medical Center in Boston.
  Area of Expertise: Internal Medicine, Neurology
  RESUME LICENSE

• Patricia Epple, RN, BS, CCRC
  Research Director
  Patricia J. Epple earned her Certification as a Clinical Research Coordinator as the site manager of the Department of Neurology at the Miriam Hospital. With her twenty years experience in the healthcare industry, she has been managing clinical research trials for over 15 years. Her responsibilities include acquisition of new clinical trials, budget negotiations, promotion and supervision of ongoing projects. Patricia is currently the Director of the Stroke Team at Miriam Hospital, responsible for enrolling patients under emergency conditions.
  RESUME LICENSE

Our affiliation with Southeastern New England's largest Academic Medical Centers allows us to draw patients from Rhode Island, Eastern Massachusetts, and Connecticut. Community based services such as "Memory and Cognitive Disorders Assessment Service" offer the most comprehensive clinic in the region for evaluation of memory loss.

CenterWatch is listing the following trials that are actively recruiting patients at this center.

• A Multicenter, Randomized, Double-Blind, Placebo-Controlled, Parallel-GroupTrial to Evaluate the Efficacy and Safety of E2007 in Patients with Painful Diabetic Neuropathy
• Phase II - Diabetic Neuropathy - Fidaristat from Sankyo Pharma, Inc.
• Phase II - Migraine Prevention Study - Patent Foramen Ovale (PFO) - St. Jude Medical Inc.
• Phase III - Alzheimer Study - Alzhemed from Neurochem, Inc.
• Phase III - Lower Back Pain Study - Latranal from Praecis, Inc.
• Phase III - Painful Diabetic Peripheral Neuropathy - Topamax from Johnson & Johnson, Inc.
• The Effectiveness And Safety Of Donepezil Hydrochloride (E2020) In Subjects With Mild To Severe Alzheimer's Disease Residing In An Assisted Living Facility
• The purpose of this study is to evaluate the safety and preliminary effectiveness of the novel compound RWJ-333369 in patients with partial onset seizures who are currently being treated with 1 or 2 concomitant antiepileptic drugs.

For more information, please contact:

Patricia J. Epple, BS, RN, CCRC
Research Director
CNS Research of RI, Inc.
P.O. Box 603153
Providence, RI 02906 USA
Phone: 1-800-707-6013 Ext. 101
Fax: 1-800-847-4332
E-mail:

If you are interested in contacting this center to discuss placing a clinical trial there, please complete and send the E-mail form below. A representative from the research center will then follow up with you.

Name:
Address:
City:
State:
Zip:
Phone:
Email address:
Message:

Please note: A number of commercial online services display an error message after you click on Send. Please be assured that your message has been received.

Last updated on February 28, 2008

PAC>